2-(3-Chloro-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

(2E)-3-(4-bromophenyl)-1-(2,5-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

N,N,3,5-Tetramethylaniline, 95.0%, 10g

tert-butyl 4-[(3-methylisoxazol-5-yl)acetyl]piperidine-1-carboxylate, 250mg

1,8-Diazaspiro[4.5]decan-2-one hydrochloride, 95.0%, 1g

{[1-(methoxymethyl)cyclopentyl]methyl}amine hydrochloride, 95.0%, 250mg

ethyl 5-amino-1-(2,3-dimethylphenyl)-1H-pyrazole-4-carboxylate, 95.0%, 1g

Azul Evans (CI 23860), 100 g

(R)-3-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95+%, 100mg

tert-Butyl 3-formyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 10g

Sodium 1,2,4-Triazolide>96.0%(GC)(T)25g

Acetona Mín. 99,5 % para envases de vidrio de síntesis Envases de vidrio de 2,5 l

4-(3-Chlorophenyl)pyrimidin-2-amine, 97%, 100mg